HilleVax, Inc.

14.99 USD
+0.05 (+0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

HilleVax, Inc. stock is up 20.3% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 December’s closed higher than November. 100% of analysts rate it a buy.

About HilleVax, Inc.

HilleVax focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

  • Guggenheim
    Wed Nov 15, 14:01
  • Stifel
    Fri Nov 10, 15:25